News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Deals
Lonza Group Ltd. (JOBS) Trumps JLL with $460 Million Patheon Bid
August 21, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Swiss drugs industry supplier Lonza has outbid private equity group JLL for Canadian rival Patheon in a deal worth $460 million, seeking to boost its manufacturing capacity.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Lonza
MORE ON THIS TOPIC
C-suite
Galapagos Takes Dramatic U-Turn, Ditching Spinout Plan, Cell Therapy and CEO Stoffels
May 13, 2025
·
2 min read
·
Annalee Armstrong
Deals
M&A, IPOs Snarled by Policy Reality in Q1 as Pharmas Opt for Licensing Deals
May 7, 2025
·
3 min read
·
Annalee Armstrong
ALS
Lilly Deepens ALS Pipeline With $415M Alchemab Licensing Deal
May 6, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Kronos Accepts $35M Concentra Buyout as Walls Close In
May 2, 2025
·
2 min read
·
Annalee Armstrong